Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

32.85

-0.29 (0.88%)

as of Jun 8, 2026, 8:00:00 pm Market Open.

172 watching

Investor Insights

Jun 7, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Extendicare Inc (EXE-T) is attracting attention for its positioning within the growing healthcare sector, particularly as it prepares to cater to an aging population in Ontario. Experts appreciate its strong chart performance and effective margin management, suggesting the company is ready to benefit from increased government funding for home healthcare providers. However, caution is advised due to the market's current exuberance and the presence of well-capitalized private equity competitors. Some analysts express concerns about the stock's current valuation, believing that much of the potential growth may already be reflected in its price. Overall, while the demographic tailwinds are favorable, there is a discernible hesitation regarding its growth prospects relative to peer companies.

Consensus

Cautious

Valuation

Fair Value

Similar

CSH.UN

DON'T BUY

Model price is around the $7 area. Overvalued.

DON'T BUY

Has been a multi year disappointment. A lot of government regulations. Costs are high.

DON'T BUY

US state legislatures limit their revenues. For demographics, would prefer retirement homes.

BUY

A bit of a value play right now. Has a big asset in some hidden real estate assets. Solid.

WEAK BUY

Bad corporate governance.

DON'T BUY

Growth has not been as great as expected. Demographics for nursing facilities is too far off.

DON'T BUY

Fair market value is $3.

DON'T BUY

Tpp exposed to the swings of the operating income.

WEAK BUY

Prefers Sunrise instead.

BUY

Good story. Has been in and out of this stock several times. At a good price now.

WEAK BUY

Government issues in US could create severe problems.

STRONG BUY

Very profitable. Should continue to turn around

TOP PICK

Have sold some assets to pay down debt. Trades at a discount to its US peers.

BUY

Has undergone a significant turn around. Refocusing from Florida operations into Ontario.

DON'T BUY

Too overleveraged.

Showing 211 to 225 of 237 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Extendicare Inc (EXE.TO)